average weight loss with glp-1 Hidden Risks of Inhibitors: Muscle and "Ozempic Face" GLP-1 Agonists Weight Loss Drugs

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for the treatment of type 2 diabetes and obesity, may modulate pathways associated with the hallmarks of aging

Understanding your metabolic profile and genetic predispositions can help inform a more personalized treatment approach with your provider

The laundry list of possible health benefits from GLP-1 drugs seems to get longer by the day, from cancer prevention to combating addiction

The future may hold medicines that prevent chronic diseases before they start, aiming for longer, healthier lives rather than just treating illness when it appears

for these drugs in 2023 (the latest year I found data for) was $71,700,000,000 (yes, 71.7 billion

Explore the link between GLP-1 agonists and fatigue, understanding why some experience this side effect.